Literature DB >> 12138273

Tuberculin skin test and anergy in dialysis patients of a tuberculosis-endemic area.

Hua-Chang Fang1, Kang-Ju Chou, Chien-Liang Chen, Po-Tsang Lee, Yee-Hsuan Chiou, Shih-Yuan Hung, Hsiao-Min Chung.   

Abstract

BACKGROUND/AIM: Uremic patients are at an increased risk of being affected by tuberculosis (TB). Periodical tuberculin skin tests were suggested to detect TB-infected patients. These were replaced by chest radiographs in endemic areas like Taiwan. However, almost 50% of the TB incidence in dialysis patients was extrapulmonary. In this study, we tried to investigate the value of tuberculin tests in dialysis patients in endemic areas.
METHODS: The patients were recruited from our dialysis unit. Purified protein derivative (PPD) and control tests with antigens for Candida and toxoid were performed using the Mantoux method. PPD with >10-mm induration will be considered positive. Skin anergy meant that the indurations of all antigens were less than 5 mm. A follow-up was done 12 months after the tests.
RESULTS: A total of 177 patients were evaluated. Anergy was found in 40 patients (22.6%). A positive predictor of anergy was age >45 years (p = 0.03), while a negative predictor was prealbumin >20 mg/dl (p = 0.04). Fifty-three patients (30%) had positive PPD tests. Seven of the positive PPD patients (13.2%) developed active TB during the following years. Among the 40 patients with skin anergy, 6 (15%) were found to have active TB. Of the 48 patients (21.1%) with indurations of the PPD tests between 5 and 10 mm, none was found to have active TB.
CONCLUSION: Although anergy will influence the sensitivity of PPD tests, these tests in combination with anergy tests could help to establish the diagnosis of TB in uremic patients, even in TB-endemic areas. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2002        PMID: 12138273     DOI: 10.1159/000065031

Source DB:  PubMed          Journal:  Nephron        ISSN: 1660-8151            Impact factor:   2.847


  4 in total

1.  Risk of tuberculosis in dialysis patients: association of tuberculin and 2,4-dinitrochlorobenzene reactivity with risk of tuberculosis.

Authors:  A I Christopoulos; A A Diamantopoulos; P A Dimopoulos; D S Gumenos; G A Barbalias
Journal:  Int Urol Nephrol       Date:  2006       Impact factor: 2.370

2.  Infections in hemodialysis: a concise review - Part 1: bacteremia and respiratory infections.

Authors:  T Eleftheriadis; V Liakopoulos; K Leivaditis; G Antoniadi; I Stefanidis
Journal:  Hippokratia       Date:  2011-01       Impact factor: 0.471

3.  Predictors and Dynamics of the Humoral and Cellular Immune Response to SARS-CoV-2 mRNA Vaccines in Hemodialysis Patients: A Multicenter Observational Study.

Authors:  Jens Van Praet; Marijke Reynders; Dirk De Bacquer; Liesbeth Viaene; Melanie K Schoutteten; Rogier Caluwé; Peter Doubel; Line Heylen; Annelies V De Bel; Bruno Van Vlem; Deborah Steensels; An S De Vriese
Journal:  J Am Soc Nephrol       Date:  2021-09-29       Impact factor: 10.121

4.  Risk factors for tuberculosis in dialysis patients: a prospective multi-center clinical trial.

Authors:  Antonios I Christopoulos; Athanasios A Diamantopoulos; Panagiotis A Dimopoulos; Demetrios S Goumenos; George A Barbalias
Journal:  BMC Nephrol       Date:  2009-11-07       Impact factor: 2.388

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.